scholarly journals Drug Supply Chain Management and Implementation of Health Reform Plan in Teaching Hospital Pharmacies of Ahvaz, Iran

2016 ◽  
Vol 1 (4) ◽  
pp. 141-145
Author(s):  
Reza Shakoori ◽  
Masoumeh Bagheri-Kahkesh
Author(s):  
Lokesh M R ◽  
Suhail Ahmed M N ◽  
Saifulla Khan

This paper provides a detailed overview of the block chain technology and how it can be used to build a foolproof system in eliminating counterfeit products in pharmaceutical industries. From the last decade, pharmaceutical companies are facing difficulties in tracking their products during the supply chain process, allowing the counterfeiters to add their fake medicines into the market. Counterfeit drugs are analysed as a very big challenge for the pharmaceutical industry worldwide. As indicated by the statistics, yearly business loss of around $200 billion is reported by US pharmaceutical companies due to these counterfeit drugs. These drugs may not help the patients to recover the disease but have many other dangerous side effects. According to the World Health Organization (WHO) survey report, in under-developed countries every 10th drug use by the consumers is counterfeit and has low quality. Hence, a system that can trace and track drug delivery at every phase is needed to solve the counterfeiting problem. The block chain has the full potential to handle and track the supply chain process very efficiently. In this paper, we have proposed and implemented a block chain based drug supply chain management. Our proposed system block chain-based drug supply chain management for consumers. In this drug supply chain management the system is deployed using Hyper ledger fabrics which is capable of continuously monitor and track the drug delivery process in the smart pharmaceutical industry. Finally, we also perform several tests to check the efficiency and usability of our proposed system.


Electronics ◽  
2020 ◽  
Vol 9 (5) ◽  
pp. 852 ◽  
Author(s):  
Khizar Abbas ◽  
Muhammad Afaq ◽  
Talha Ahmed Khan ◽  
Wang-Cheol Song

From the last decade, pharmaceutical companies are facing difficulties in tracking their products during the supply chain process, allowing the counterfeiters to add their fake medicines into the market. Counterfeit drugs are analyzed as a very big challenge for the pharmaceutical industry worldwide. As indicated by the statistics, yearly business loss of around $200 billion is reported by US pharmaceutical companies due to these counterfeit drugs. These drugs may not help the patients to recover the disease but have many other dangerous side effects. According to the World Health Organization (WHO) survey report, in under-developed countries every 10th drug use by the consumers is counterfeit and has low quality. Hence, a system that can trace and track drug delivery at every phase is needed to solve the counterfeiting problem. The blockchain has the full potential to handle and track the supply chain process very efficiently. In this paper, we have proposed and implemented a novel blockchain and machine learning-based drug supply chain management and recommendation system (DSCMR). Our proposed system consists of two main modules: blockchain-based drug supply chain management and machine learning-based drug recommendation system for consumers. In the first module, the drug supply chain management system is deployed using Hyperledger fabrics which is capable of continuously monitor and track the drug delivery process in the smart pharmaceutical industry. On the other hand, the N-gram, LightGBM models are used in the machine learning module to recommend the top-rated or best medicines to the customers of the pharmaceutical industry. These models have trained on well known publicly available drug reviews dataset provided by the UCI: an open-source machine learning repository. Moreover, the machine learning module is integrated with this blockchain system with the help of the REST API. Finally, we also perform several tests to check the efficiency and usability of our proposed system.


2021 ◽  
Vol 4 (2) ◽  
pp. 281-291
Author(s):  
Theogene Hakuzimana ◽  
Pierre Claver Kayumba ◽  
Innocent Hahirwa ◽  
Max Kabalisa

BackgroundRegardless of the significant efforts used and put in place to enhance supply chain performance in Rwanda, there is still poor inventory management and big loss due to expiry of medicines at Medical Procurement and Production Division (MPPD).ObjectiveTo assess the factors that contributes to expiry of medicines at MPPD and formulate recommendations for the improvement of the current situation.MethodsThis is a descriptive cross-sectional study used for 25 respondents. A questionnaire containing closed-ended questions was used focusing on factors contributing to expiries of medicines for each product category managed by MPPD from 2014-2018. Additionally, the researcher reviewed all inventory reports, including expiries for the same period under study. The study focused on targeting respondents working at MPPD as pharmacists both technical and administrative, also other non-pharmacist working in the warehouse were considered as respondents. The hard copy of questionnaire was handed over to 26 respondents and requested to provide filled questionnaire within seven days. Twenty-five respondents were able to return the filled questionnaire on time, giving 96% response rate.ResultsThe study found that in MPPD, medicines are still expiring. During five years (from 2014 up to 2018) the total expired products were valued at RWF 6,046,778,655 for all program categories: HIV commodities had the largest share 53.3%, Essential Medicines 22.5%, Malaria 13%, Maternal Child Health commodities 5.7%, Products used for Community health workers 4.5%, TB products 1% and 0.1% for Family Planning products. The study found that major contributing factors for expiry of health commodities at MPPD, are ranked as follows: Supply chain management 90%, other factors 73%, Poor storage management 68% and Excessive drug supply 67%. ConclusionConsidering the study results, it looks like no significant effect of excessive drug supply and inventory management on the expiration of medicines at MPPD. However, the Supply Chain Management components are the most vulnerable to contribute to the expiration of medicines at MPPD. There are many changes to be done inside the institution to remedy the issue of expiration like working according to the standard operating procedures, improving the Skills of personnel in supply chain management, empowering the procurement unit with skilled personnel and improving the communication with stakeholders to facilitate the smooth and quick replenishment and distribution of the stock. Rwanda J Med Health Sci 2021;4(2): 281-291


2022 ◽  
pp. 220-243
Author(s):  
Neeta Baporikar

Safeguarding the supply of drugs and satisfying the needs of patients is a strategic priority of any healthcare system especially in these pandemic times. The pharmaceutical supply chain is subject to many pressures including non-availability and shortage of requisite drugs. A drug shortage is a deficiency in the supply of medicines or products that affects the ability of a patient to get the required treatment in due time. The roots of drug shortages are multifaceted, varied, and the issue can be due to supply or demand. However, the situation affects almost every stakeholder in the healthcare system, which is why collaboration is a must to deal with drug shortages. Hence, adopting an exploratory and single-case approach of the largest public hospital in the context of Namibia, the objective of this chapter is to provide a contemporary perspective of supply chain management re drug sourcing shortages, analyze the causes of drug shortages, recommend measures to minimize the crisis, and suggest strategies for enhanced efficiency in drug supply.


Sign in / Sign up

Export Citation Format

Share Document